Raghuram Selvaraju
Stock Analyst at HC Wainwright & Co.
(1.94)
# 1,663
Out of 4,458 analysts
644
Total ratings
35.4%
Success rate
n/a
Average return
Main Sectors:
91 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics | Maintains: Buy | $9 → $3 | $0.79 | +279.94% | 3 | Jun 18, 2024 | |
| PYPD PolyPid | Reiterates: Buy | $14 | $4.19 | +234.53% | 4 | Jun 18, 2024 | |
| SCLX Scilex Holding Company | Reiterates: Buy | $7 | $2.15 | +225.58% | 6 | Jun 17, 2024 | |
| INDP Indaptus Therapeutics | Reiterates: Buy | $12 | $2.44 | +391.80% | 11 | Jun 17, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $54 → $60 | $18.28 | +228.23% | 19 | Jun 14, 2024 | |
| PCSA Processa Pharmaceuticals | Reiterates: Buy | $8 | $1.85 | +332.43% | 3 | Jun 12, 2024 | |
| ANVS Annovis Bio | Reiterates: Buy | $23 | $5.51 | +317.42% | 13 | Jun 12, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $100 | $40.17 | +148.94% | 21 | Jun 11, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $20 → $14 | $1.45 | +865.52% | 12 | Jun 11, 2024 | |
| ENLV Enlivex Therapeutics | Maintains: Buy | $7 → $6 | $1.39 | +331.65% | 10 | Jun 11, 2024 | |
| AVXL Anavex Life Sciences | Reiterates: Buy | $40 | $3.73 | +972.39% | 16 | Jun 11, 2024 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $190 | $76.00 | +150.00% | 20 | Jun 6, 2024 | |
| BBIO BridgeBio Pharma | Reiterates: Buy | $43 | $27.23 | +57.91% | 9 | Jun 5, 2024 | |
| SPRB Spruce Biosciences | Reiterates: Neutral | n/a | $0.65 | - | 10 | Jun 5, 2024 | |
| EQ Equillium | Reiterates: Buy | $5 | $0.72 | +597.74% | 10 | Jun 5, 2024 | |
| AQST Aquestive Therapeutics | Reiterates: Buy | $9 | $2.73 | +229.67% | 16 | Jun 5, 2024 | |
| ENTX Entera Bio | Reiterates: Buy | $10 | $2.07 | +383.09% | 11 | Jun 5, 2024 | |
| BWAY BrainsWay | Reiterates: Buy | $15 | $6.03 | +148.76% | 15 | Jun 5, 2024 | |
| MBOT Microbot Medical | Reiterates: Buy | $7 | $1.04 | +573.08% | 6 | Jun 3, 2024 | |
| GMAB Genmab | Reiterates: Buy | $50 | $25.78 | +93.95% | 32 | Jun 3, 2024 | |
| GANX Gain Therapeutics | Reiterates: Buy | $9 | $1.32 | +581.82% | 13 | May 31, 2024 | |
| ONCT Oncternal Therapeutics | Reiterates: Buy | $19 | $8.23 | +130.86% | 11 | May 31, 2024 | |
| CGTX Cognition Therapeutics | Initiates: Buy | $10 | $2.19 | +356.62% | 1 | May 29, 2024 | |
| RKDA Arcadia Biosciences | Maintains: Buy | $10 → $6 | $3.16 | +89.87% | 11 | May 23, 2024 | |
| SLGL Sol-Gel Technologies | Reiterates: Buy | $6 | $0.86 | +597.19% | 15 | May 22, 2024 | |
| ORMP Oramed Pharmaceuticals | Reiterates: Neutral | n/a | $2.24 | - | 4 | May 20, 2024 | |
| LGVN Longeveron | Reiterates: Buy | $12 | $2.40 | +400.00% | 3 | May 17, 2024 | |
| FATE Fate Therapeutics | Maintains: Neutral | $7 → $5 | $3.57 | +40.06% | 3 | May 16, 2024 | |
| RMTI Rockwell Medical | Reiterates: Buy | $9 | $1.85 | +387.80% | 17 | May 16, 2024 | |
| SPRO Spero Therapeutics | Reiterates: Buy | $7 | $1.28 | +446.88% | 13 | May 16, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $18 → $15 | $6.81 | +120.26% | 9 | May 15, 2024 | |
| VRNA Verona Pharma | Reiterates: Buy | n/a | $16.66 | - | 15 | May 15, 2024 | |
| COCP Cocrystal Pharma | Reiterates: Buy | n/a | $2.41 | - | 13 | May 14, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $7.5 → $10 | $10.44 | -4.21% | 13 | May 10, 2024 | |
| BTAI BioXcel Therapeutics | Reiterates: Buy | $10 | $1.33 | +651.88% | 30 | May 10, 2024 | |
| KZR Kezar Life Sciences | Reiterates: Buy | $20 | $0.66 | +2,912.05% | 12 | May 10, 2024 | |
| RGLS Regulus Therapeutics | Reiterates: Buy | $9 | $2.37 | +279.75% | 11 | May 10, 2024 | |
| CDXC ChromaDex | Reiterates: Buy | $6 | $2.96 | +102.70% | 12 | May 9, 2024 | |
| BCPC Balchem | Maintains: Buy | $167 → $170 | $153.84 | +10.50% | 14 | May 6, 2024 | |
| CRDF Cardiff Oncology | Reiterates: Buy | $14 | $2.67 | +424.34% | 12 | May 6, 2024 | |
| RAPT RAPT Therapeutics | Reiterates: Neutral | n/a | $3.31 | - | 16 | Apr 10, 2024 | |
| HOTH Hoth Therapeutics | Reiterates: Buy | $4 | $0.92 | +332.81% | 2 | Apr 5, 2024 | |
| TRDA Entrada Therapeutics | Reiterates: Buy | $20 | $15.21 | +31.49% | 7 | Mar 18, 2024 | |
| ACRS Aclaris Therapeutics | Downgrades: Neutral | n/a | $1.13 | - | 11 | Jan 22, 2024 | |
| TARO Taro Pharmaceutical Industries | Downgrades: Neutral | $43 | $42.80 | +0.47% | 8 | Jan 18, 2024 | |
| CING Cingulate | Maintains: Buy | $3.5 → $8 | $0.67 | +1,094.03% | 3 | Jan 5, 2024 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $10 | $3.35 | +198.51% | 9 | Dec 11, 2023 | |
| PXMD PaxMedica | Initiates: Buy | $3 | $0.26 | +1,076.47% | 1 | Dec 4, 2023 | |
| PLX Protalix BioTherapeutics | Reiterates: Buy | $10 | $1.11 | +800.90% | 4 | Nov 14, 2023 | |
| AEZS Aeterna Zentaris | Maintains: Buy | $112 → $60 | $5.91 | +915.23% | 10 | Nov 13, 2023 | |
| GLTO Galecto | Downgrades: Neutral | n/a | $0.51 | - | 5 | Sep 28, 2023 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $9 → $7 | $0.53 | +1,228.02% | 2 | Sep 25, 2023 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Buy | $6 | $2.03 | +195.57% | 2 | Sep 25, 2023 | |
| GRTX Galera Therapeutics | Downgrades: Neutral | $6 → $0.3 | $0.09 | +233.33% | 6 | Aug 16, 2023 | |
| EVFM Evofem Biosciences | Maintains: Buy | $250 → $500 | $0.01 | +4,237,188.14% | 6 | Aug 15, 2022 | |
| ADXN Addex Therapeutics | Downgrades: Neutral | n/a | $7.99 | - | 4 | Jun 23, 2022 | |
| TYRA Tyra Biosciences | Initiates: Buy | $12 | $17.75 | -32.39% | 1 | Jun 23, 2022 | |
| NBSE NeuBase Therapeutics | Maintains: Buy | $300 → $200 | $0.38 | +52,810.05% | 3 | May 31, 2022 | |
| INM InMed Pharmaceuticals | Initiates: Buy | n/a | $0.22 | - | 1 | Nov 29, 2021 | |
| ABEO Abeona Therapeutics | Maintains: Buy | n/a | $4.51 | - | 3 | Nov 29, 2021 | |
| OMER Omeros | Maintains: Buy | n/a | $4.04 | - | 4 | Oct 19, 2021 | |
| SYBX Synlogic | Maintains: Buy | n/a | $1.59 | - | 2 | Oct 13, 2021 | |
| RDHL RedHill Biopharma | Maintains: Buy | n/a | $0.40 | - | 2 | Sep 15, 2021 | |
| IMUX Immunic | Maintains: Buy | n/a | $1.14 | - | 3 | Sep 7, 2021 | |
| XCUR Exicure | Maintains: Buy | n/a | $0.32 | - | 1 | May 17, 2021 | |
| RGEN Repligen | Maintains: Buy | n/a | $124.35 | - | 5 | May 5, 2021 | |
| BHC Bausch Health Companies | Maintains: Buy | n/a | $6.43 | - | 4 | Mar 16, 2021 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $775 → $925 | $1.93 | +47,827.46% | 2 | Mar 5, 2021 | |
| NRBO NeuroBo Pharmaceuticals | Maintains: Buy | $4,800 → $3,840 | $3.83 | +100,234.45% | 2 | Feb 1, 2021 | |
| APDN Applied DNA Sciences | Maintains: Buy | $360 → $280 | $0.46 | +60,769.57% | 5 | Jan 14, 2021 | |
| CDNA CareDx | Maintains: Buy | n/a | $13.54 | - | 3 | Aug 5, 2020 | |
| CYDY CytoDyn | Downgrades: Neutral | n/a | $0.13 | - | 1 | Jul 6, 2020 | |
| REPL Replimune Group | Downgrades: Neutral | n/a | $7.81 | - | 1 | Jul 1, 2020 | |
| IGMS IGM Biosciences | Initiates: Buy | n/a | $7.31 | - | 1 | Jul 1, 2020 | |
| INO Inovio Pharmaceuticals | Downgrades: Neutral | n/a | $8.94 | - | 3 | Jun 29, 2020 | |
| EVOK Evoke Pharma | Upgrades: Buy | n/a | $0.53 | - | 2 | Jun 22, 2020 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $20.25 | - | 1 | Mar 23, 2020 | |
| SWTX SpringWorks Therapeutics | Upgrades: Buy | n/a | $36.67 | - | 1 | Mar 19, 2020 | |
| CELC Celcuity | Initiates: Buy | n/a | $14.61 | - | 1 | Nov 20, 2018 | |
| CTMX CytomX Therapeutics | Initiates: Buy | n/a | $1.37 | - | 1 | Sep 13, 2018 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | n/a | $5.75 | - | 1 | Aug 24, 2018 | |
| CRMD CorMedix | Maintains: Buy | n/a | $4.49 | - | 1 | May 23, 2018 | |
| CHEK Check-Cap | Maintains: Buy | n/a | $2.24 | - | 1 | May 23, 2018 | |
| TTOO T2 Biosystems | Maintains: Buy | $40,000 → $42,500 | $5.13 | +828,360.04% | 2 | Mar 29, 2018 | |
| DRRX DURECT | Upgrades: Buy | n/a | $1.78 | - | 3 | Mar 6, 2018 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | n/a | $25.66 | - | 3 | Mar 5, 2018 | |
| AEMD Aethlon Medical | Initiates: Buy | n/a | $0.64 | - | 1 | Nov 20, 2017 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $18,000 → $6,000 | $2.39 | +250,946.03% | 1 | Nov 13, 2017 | |
| IMRN Immuron | Initiates: Buy | n/a | $2.10 | - | 1 | Oct 18, 2017 | |
| OCUL Ocular Therapeutix | Initiates: Buy | n/a | $5.50 | - | 1 | Jul 26, 2017 | |
| ALIM Alimera Sciences | Initiates: Buy | n/a | $3.25 | - | 1 | Apr 27, 2017 |
Ovid Therapeutics
Jun 18, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $0.79
Upside: +279.94%
PolyPid
Jun 18, 2024
Reiterates: Buy
Price Target: $14
Current: $4.19
Upside: +234.53%
Scilex Holding Company
Jun 17, 2024
Reiterates: Buy
Price Target: $7
Current: $2.15
Upside: +225.58%
Indaptus Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $12
Current: $2.44
Upside: +391.80%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $54 → $60
Current: $18.28
Upside: +228.23%
Processa Pharmaceuticals
Jun 12, 2024
Reiterates: Buy
Price Target: $8
Current: $1.85
Upside: +332.43%
Annovis Bio
Jun 12, 2024
Reiterates: Buy
Price Target: $23
Current: $5.51
Upside: +317.42%
MoonLake Immunotherapeutics
Jun 11, 2024
Reiterates: Buy
Price Target: $100
Current: $40.17
Upside: +148.94%
Reviva Pharmaceuticals Holdings
Jun 11, 2024
Maintains: Buy
Price Target: $20 → $14
Current: $1.45
Upside: +865.52%
Enlivex Therapeutics
Jun 11, 2024
Maintains: Buy
Price Target: $7 → $6
Current: $1.39
Upside: +331.65%
Anavex Life Sciences
Jun 11, 2024
Reiterates: Buy
Price Target: $40
Current: $3.73
Upside: +972.39%
Axsome Therapeutics
Jun 6, 2024
Reiterates: Buy
Price Target: $190
Current: $76.00
Upside: +150.00%
BridgeBio Pharma
Jun 5, 2024
Reiterates: Buy
Price Target: $43
Current: $27.23
Upside: +57.91%
Spruce Biosciences
Jun 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.65
Upside: -
Equillium
Jun 5, 2024
Reiterates: Buy
Price Target: $5
Current: $0.72
Upside: +597.74%
Aquestive Therapeutics
Jun 5, 2024
Reiterates: Buy
Price Target: $9
Current: $2.73
Upside: +229.67%
Entera Bio
Jun 5, 2024
Reiterates: Buy
Price Target: $10
Current: $2.07
Upside: +383.09%
BrainsWay
Jun 5, 2024
Reiterates: Buy
Price Target: $15
Current: $6.03
Upside: +148.76%
Microbot Medical
Jun 3, 2024
Reiterates: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Genmab
Jun 3, 2024
Reiterates: Buy
Price Target: $50
Current: $25.78
Upside: +93.95%
Gain Therapeutics
May 31, 2024
Reiterates: Buy
Price Target: $9
Current: $1.32
Upside: +581.82%
Oncternal Therapeutics
May 31, 2024
Reiterates: Buy
Price Target: $19
Current: $8.23
Upside: +130.86%
Cognition Therapeutics
May 29, 2024
Initiates: Buy
Price Target: $10
Current: $2.19
Upside: +356.62%
Arcadia Biosciences
May 23, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $3.16
Upside: +89.87%
Sol-Gel Technologies
May 22, 2024
Reiterates: Buy
Price Target: $6
Current: $0.86
Upside: +597.19%
Oramed Pharmaceuticals
May 20, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.24
Upside: -
Longeveron
May 17, 2024
Reiterates: Buy
Price Target: $12
Current: $2.40
Upside: +400.00%
Fate Therapeutics
May 16, 2024
Maintains: Neutral
Price Target: $7 → $5
Current: $3.57
Upside: +40.06%
Rockwell Medical
May 16, 2024
Reiterates: Buy
Price Target: $9
Current: $1.85
Upside: +387.80%
Spero Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $7
Current: $1.28
Upside: +446.88%
Fennec Pharmaceuticals
May 15, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $6.81
Upside: +120.26%
Verona Pharma
May 15, 2024
Reiterates: Buy
Price Target: n/a
Current: $16.66
Upside: -
Cocrystal Pharma
May 14, 2024
Reiterates: Buy
Price Target: n/a
Current: $2.41
Upside: -
ADMA Biologics
May 10, 2024
Maintains: Buy
Price Target: $7.5 → $10
Current: $10.44
Upside: -4.21%
BioXcel Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
Kezar Life Sciences
May 10, 2024
Reiterates: Buy
Price Target: $20
Current: $0.66
Upside: +2,912.05%
Regulus Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $9
Current: $2.37
Upside: +279.75%
ChromaDex
May 9, 2024
Reiterates: Buy
Price Target: $6
Current: $2.96
Upside: +102.70%
Balchem
May 6, 2024
Maintains: Buy
Price Target: $167 → $170
Current: $153.84
Upside: +10.50%
Cardiff Oncology
May 6, 2024
Reiterates: Buy
Price Target: $14
Current: $2.67
Upside: +424.34%
RAPT Therapeutics
Apr 10, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.31
Upside: -
Hoth Therapeutics
Apr 5, 2024
Reiterates: Buy
Price Target: $4
Current: $0.92
Upside: +332.81%
Entrada Therapeutics
Mar 18, 2024
Reiterates: Buy
Price Target: $20
Current: $15.21
Upside: +31.49%
Aclaris Therapeutics
Jan 22, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
Taro Pharmaceutical Industries
Jan 18, 2024
Downgrades: Neutral
Price Target: $43
Current: $42.80
Upside: +0.47%
Cingulate
Jan 5, 2024
Maintains: Buy
Price Target: $3.5 → $8
Current: $0.67
Upside: +1,094.03%
Eton Pharmaceuticals
Dec 11, 2023
Reiterates: Buy
Price Target: $10
Current: $3.35
Upside: +198.51%
PaxMedica
Dec 4, 2023
Initiates: Buy
Price Target: $3
Current: $0.26
Upside: +1,076.47%
Protalix BioTherapeutics
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.11
Upside: +800.90%
Aeterna Zentaris
Nov 13, 2023
Maintains: Buy
Price Target: $112 → $60
Current: $5.91
Upside: +915.23%
Galecto
Sep 28, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.51
Upside: -
Ensysce Biosciences
Sep 25, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $0.53
Upside: +1,228.02%
Anebulo Pharmaceuticals
Sep 25, 2023
Reiterates: Buy
Price Target: $6
Current: $2.03
Upside: +195.57%
Galera Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: $6 → $0.3
Current: $0.09
Upside: +233.33%
Evofem Biosciences
Aug 15, 2022
Maintains: Buy
Price Target: $250 → $500
Current: $0.01
Upside: +4,237,188.14%
Addex Therapeutics
Jun 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $7.99
Upside: -
Tyra Biosciences
Jun 23, 2022
Initiates: Buy
Price Target: $12
Current: $17.75
Upside: -32.39%
NeuBase Therapeutics
May 31, 2022
Maintains: Buy
Price Target: $300 → $200
Current: $0.38
Upside: +52,810.05%
InMed Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $0.22
Upside: -
Abeona Therapeutics
Nov 29, 2021
Maintains: Buy
Price Target: n/a
Current: $4.51
Upside: -
Omeros
Oct 19, 2021
Maintains: Buy
Price Target: n/a
Current: $4.04
Upside: -
Synlogic
Oct 13, 2021
Maintains: Buy
Price Target: n/a
Current: $1.59
Upside: -
RedHill Biopharma
Sep 15, 2021
Maintains: Buy
Price Target: n/a
Current: $0.40
Upside: -
Immunic
Sep 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.14
Upside: -
Exicure
May 17, 2021
Maintains: Buy
Price Target: n/a
Current: $0.32
Upside: -
Repligen
May 5, 2021
Maintains: Buy
Price Target: n/a
Current: $124.35
Upside: -
Bausch Health Companies
Mar 16, 2021
Maintains: Buy
Price Target: n/a
Current: $6.43
Upside: -
TFF Pharmaceuticals
Mar 5, 2021
Maintains: Buy
Price Target: $775 → $925
Current: $1.93
Upside: +47,827.46%
NeuroBo Pharmaceuticals
Feb 1, 2021
Maintains: Buy
Price Target: $4,800 → $3,840
Current: $3.83
Upside: +100,234.45%
Applied DNA Sciences
Jan 14, 2021
Maintains: Buy
Price Target: $360 → $280
Current: $0.46
Upside: +60,769.57%
CareDx
Aug 5, 2020
Maintains: Buy
Price Target: n/a
Current: $13.54
Upside: -
CytoDyn
Jul 6, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.13
Upside: -
Replimune Group
Jul 1, 2020
Downgrades: Neutral
Price Target: n/a
Current: $7.81
Upside: -
IGM Biosciences
Jul 1, 2020
Initiates: Buy
Price Target: n/a
Current: $7.31
Upside: -
Inovio Pharmaceuticals
Jun 29, 2020
Downgrades: Neutral
Price Target: n/a
Current: $8.94
Upside: -
Evoke Pharma
Jun 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.53
Upside: -
BioLife Solutions
Mar 23, 2020
Maintains: Buy
Price Target: n/a
Current: $20.25
Upside: -
SpringWorks Therapeutics
Mar 19, 2020
Upgrades: Buy
Price Target: n/a
Current: $36.67
Upside: -
Celcuity
Nov 20, 2018
Initiates: Buy
Price Target: n/a
Current: $14.61
Upside: -
CytomX Therapeutics
Sep 13, 2018
Initiates: Buy
Price Target: n/a
Current: $1.37
Upside: -
Kala Pharmaceuticals
Aug 24, 2018
Maintains: Buy
Price Target: n/a
Current: $5.75
Upside: -
CorMedix
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $4.49
Upside: -
Check-Cap
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $2.24
Upside: -
T2 Biosystems
Mar 29, 2018
Maintains: Buy
Price Target: $40,000 → $42,500
Current: $5.13
Upside: +828,360.04%
DURECT
Mar 6, 2018
Upgrades: Buy
Price Target: n/a
Current: $1.78
Upside: -
DENTSPLY SIRONA
Mar 5, 2018
Maintains: Neutral
Price Target: n/a
Current: $25.66
Upside: -
Aethlon Medical
Nov 20, 2017
Initiates: Buy
Price Target: n/a
Current: $0.64
Upside: -
Bio-Path Holdings
Nov 13, 2017
Maintains: Buy
Price Target: $18,000 → $6,000
Current: $2.39
Upside: +250,946.03%
Immuron
Oct 18, 2017
Initiates: Buy
Price Target: n/a
Current: $2.10
Upside: -
Ocular Therapeutix
Jul 26, 2017
Initiates: Buy
Price Target: n/a
Current: $5.50
Upside: -
Alimera Sciences
Apr 27, 2017
Initiates: Buy
Price Target: n/a
Current: $3.25
Upside: -